Lipophilic index of serum phospholipids in patients with type 2 diabetes and atherosclerotic cardiovascular disease: links with metabolic control, vascular inflammation and platelet activation
In well-controlled T2D patients with ASCVD, the higher serum phospholipid LI is associated with worse glucometabolic control, enhanced vascular inflammation and higher platelet reactivity during aspirin treatment at cyclooxygenase-1-selective doses.
Authors
- Jadwiga Nessler (ORCID: https://orcid.org/0000-0002-5076-5816)
- Grzegorz Gajos (ORCID: https://orcid.org/0000-0002-7361-3559)
- Dominika Drwiła-Stec
- Konrad Stępień (ORCID: https://orcid.org/0000-0002-5779-8434)
- Paweł Rostoff (ORCID: https://orcid.org/0000-0003-4942-4587)
- Anna Majda (ORCID: https://orcid.org/0000-0001-7850-1698)
Institutions
- Jagiellonian University (PL)
- John Paul II Hospital (PL)
- Institute of Cardiology (PL)
- Corona (Poland) (PL)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1186/s12933-024-02506-6
- Citations
- 3
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- Uniwersytet Jagielloński Collegium Medicum
- Narodowe Centrum Nauki